When are steroids indicated in a patient with pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroids in Pneumonia: When to Use and When to Avoid

Use low-dose corticosteroids (≤400 mg hydrocortisone equivalent daily for 5-7 days) in patients with severe community-acquired pneumonia requiring ICU admission, particularly those with septic shock requiring vasopressors, but avoid steroids entirely in influenza pneumonia and do not use them routinely in non-severe pneumonia. 1, 2, 3

Specific Indications for Steroid Use

Severe Community-Acquired Pneumonia (CAP) with Septic Shock

  • Initiate hydrocortisone 50 mg IV every 6 hours plus fludrocortisone 50 μg daily for 7 days in patients with severe CAP and refractory septic shock requiring vasopressors despite adequate fluid resuscitation. 2, 3
  • This regimen reduces mortality with an absolute risk reduction of approximately 9.8% (number needed to treat = 18 patients to prevent one death). 2, 4
  • The mortality benefit is most pronounced in severe CAP (RR 0.58,95% CI 0.40-0.84), not in non-severe cases. 5, 3

Severe CAP Requiring ICU Admission (Without Shock)

  • Consider low-dose corticosteroids (hydrocortisone ≤400 mg/day equivalent or methylprednisolone 0.5 mg/kg IV every 12 hours for 5 days) in ICU patients with severe CAP who have elevated inflammatory markers (CRP >150 mg/L). 1, 3
  • Benefits include reduced mechanical ventilation need (RR 0.45), prevention of ARDS (RR 0.24), and shortened hospital stay by approximately 3 days. 1, 3

Screening for Adrenal Insufficiency

  • Screen hypotensive, fluid-resuscitated patients with severe CAP for occult adrenal insufficiency using cortisol stimulation testing. 2
  • Provide stress-dose steroids (200-300 mg hydrocortisone per day) if inadequate cortisol response is documented. 3
  • Patients with underlying COPD warrant particular attention for screening due to frequent intermittent steroid use. 2

Absolute Contraindications

Influenza Pneumonia

  • Never use corticosteroids in influenza pneumonia—meta-analyses consistently demonstrate increased mortality (OR 3.06,95% CI 1.58-5.92) and increased risk of superinfection. 1, 2, 3

Non-Severe CAP

  • Do not use steroids routinely in mild-to-moderate CAP requiring hospitalization but not ICU care—there is no mortality benefit and a strong recommendation against routine use. 2, 3
  • Steroids have no place in non-severe pneumonia treatment according to multiple guidelines. 2

Dosing Parameters When Indicated

  • Do not exceed 400 mg hydrocortisone equivalent daily (or methylprednisolone 1-2 mg/kg/day). 3
  • Limit duration to 5-7 days to minimize complications. 1, 3
  • Avoid high-dose steroids (hydrocortisone ≥300 mg/day or prednisolone ≥75 mg/day) as they increase hospital-acquired infections, hyperglycemia, and GI bleeding without mortality benefit. 3
  • Taper slowly to prevent rebound phenomenon. 6

Mandatory Monitoring and Prophylaxis

Hyperglycemia Management

  • Monitor glucose closely—hyperglycemia occurs in nearly twice as many steroid-treated patients (RR 1.72,95% CI 1.38-2.14) and is the most common adverse effect requiring intervention. 1, 3, 5

GI Protection

  • Provide proton pump inhibitor prophylaxis for all patients receiving steroids to prevent GI bleeding. 3

Infection Surveillance

  • Maintain vigilant infection surveillance, as secondary infections remain a concern despite non-significant statistical differences in trials. 2, 6
  • Consider Pneumocystis pneumonia prophylaxis for patients receiving ≥20 mg methylprednisolone equivalent for ≥4 weeks. 3

Additional Monitoring

  • Supplement with calcium and vitamin D for prolonged steroid courses. 3
  • Watch for increased rehospitalization rates in the 30-90 days following treatment. 3

Clinical Decision Algorithm

Step 1: Identify pneumonia severity

  • Severe CAP = ICU admission required, septic shock, or APACHE II score ≥25. 2
  • PaO2/FiO2 ratio <150 indicates severe hypoxemia requiring aggressive management. 2

Step 2: Exclude contraindications

  • Rule out influenza pneumonia (absolutely contraindicated). 1, 2, 3
  • Confirm bacterial CAP, not viral pneumonia. 2

Step 3: Apply steroids only if:

  • Severe CAP with septic shock requiring vasopressors after adequate fluid resuscitation, OR 2, 3
  • Severe CAP requiring ICU admission with CRP >150 mg/L, OR 3
  • Documented adrenal insufficiency on cortisol stimulation testing. 2, 3

Step 4: Do NOT use steroids if:

  • Non-severe CAP (hospitalized but not ICU). 2, 3
  • Influenza pneumonia confirmed or suspected. 1, 2, 3
  • Mild-to-moderate pneumonia without shock or ICU requirement. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Steroid Use in Pneumonia: Clinical Indications and Laboratory Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Steroids in High-Risk Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Corticosteroids for pneumonia.

The Cochrane database of systematic reviews, 2017

Research

To use or not to use corticosteroids for pneumonia? A clinician's perspective.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.